24. In the following year, WuXi Biologics expects to generate $ 269 million in free cash flow, which is projected to rise at a pace of 37% every year afterward. WuXi Biologics has a 100 percent equity cost of capital, an 87 percent debt cost of capital, and a corporation tax rate of 35 percent. Assume WuXi Biologics' debt-to-equity ratio is currently 0.05. Required: a) What is the value of WuXi Biologics as an all-equity firm? (5 marks) b) What is the value of WuXi Biologics as a levered firm? (5 marks) c) What is the value of WuXi Biologics' interest tax shield? (2 marks)